Molecular Imaging in Early Skin Cancer Detection: Advances, Limitations, and Future Directions

Area of Science:

• Oncologic Imaging
• Dermatology
• Molecular Biology

Background:

• Early skin cancer detection is vital for effective treatment and patient outcomes.
• Molecular imaging advances enable visualization of tumors and cellular activities at the molecular level.
• Traditional imaging methods may miss early-stage cancers.

Purpose of the Study:

• To review imaging modalities for skin cancer diagnosis.
• To highlight the advantages and limitations of various techniques.
• To emphasize the potential of molecular imaging for early detection, personalized treatment, and response monitoring.

Main Methods:

• Review of current literature on skin cancer imaging modalities.
• Focus on molecular imaging techniques including reflectance confocal microscopy (RCM), optical coherence tomography (OCT), and skin fluorescent imaging (SFI).
• Integration of in vivo molecular imaging with tumor biomarkers.

Main Results:

• RCM and OCT provide near-histologic detail of skin.
• SFI targets αvβ3 integrin expression for melanoma detection.
• Molecular imaging offers precise insights into cancer biology.

Conclusions:

• Molecular imaging techniques show promise for non-invasive early detection of melanoma.
• Integration of molecular imaging and biomarkers enhances diagnosis, prognosis, and personalized treatment strategies.
• Molecular imaging is crucial for improving early detection, personalizing treatment, and monitoring therapeutic responses in skin cancer.